{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:12:18Z","timestamp":1784772738577,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,10,29]],"date-time":"2013-10-29T00:00:00Z","timestamp":1383004800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00296-013-2885-y","type":"journal-article","created":{"date-parts":[[2013,10,28]],"date-time":"2013-10-28T10:59:38Z","timestamp":1382957978000},"page":"235-241","source":"Crossref","is-referenced-by-count":7,"title":["Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sj\u00f6gren\u2019s syndrome?"],"prefix":"10.1007","volume":"34","author":[{"given":"Gintaras","family":"Sudzius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mieliauskaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almantas","family":"Siaurys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Viliene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Butrimiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dainius","family":"Characiejus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Dumalakiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,29]]},"reference":[{"key":"2885_CR1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1313.004","volume":"1050","author":"JO Pers","year":"2005","unstructured":"Pers JO, Daridon C, Devauchelle V, Jousse S, Saraux A, Jamin C, Youinou P (2005) BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 1050:34\u201339. doi: 10.1196\/annals.1313.004","journal-title":"Ann N Y Acad Sci"},{"key":"2885_CR2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558. doi: 10.1136\/ard.61.6.554","journal-title":"Ann Rheum Dis"},{"key":"2885_CR3","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/ard.2008.095257","volume":"68","author":"S Candon","year":"2009","unstructured":"Candon S, Gottenberg JE, Bengoufa D, Chatenoud L, Mariette X (2009) Quantitative assessment of antibodies to ribonucleoproteins in primary Sj\u00f6gren syndrome: correlation with B-cell biomarkers and disease activity. Ann Rheum Dis 68:1208\u20131212. doi: 10.1136\/ard.2008.095257","journal-title":"Ann Rheum Dis"},{"key":"2885_CR4","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/ard.2004.030643","volume":"64","author":"JE Gottenberg","year":"2005","unstructured":"Gottenberg JE, Busson M, Cohen-Solal J, Lavie F, Abbed K, Kimberly RP et al (2005) Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren\u2019s syndrome. Ann Rheum Dis 64:1050\u20131055. doi: 10.1136\/ard.2004.030643","journal-title":"Ann Rheum Dis"},{"key":"2885_CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ard.2006.052159","volume":"66","author":"JE Gottenberg","year":"2007","unstructured":"Gottenberg JE, Aucouturier F, Goetz J, Sordet C, Jahn I, Busson M et al (2007) Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren\u2019s syndrome. Ann Rheum Dis 66:23\u201327. doi: 10.1136\/ard.2006.052159","journal-title":"Ann Rheum Dis"},{"key":"2885_CR6","unstructured":"Gottenberg JE, Seror R, Benessiano J, Inamo K, Dieude P, Dubost JJ et al (2010) Correlation of Serum BAFF and Markers of B-Cell Activation with Systemic Involvement Assessed by the EULAR Sj\u00f6gren\u2019s Syndrome Disease Activity Index: Results from the ASSESS Prospective Cohort. [abstract]. Arthritis Rheum 62 Suppl 10:1890. doi: 10.1002\/art.29655"},{"key":"2885_CR7","doi-asserted-by":"crossref","first-page":"e59868","DOI":"10.1371\/journal.pone.0059868","volume":"8","author":"J-E Gottenberg","year":"2013","unstructured":"Gottenberg J-E, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P et al (2013) Serum levels of Beta2-Microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sj\u00f6gren\u2019s syndrome. Data at enrollment in the prospective ASSESS cohort. PLoS One 8:e59868. doi: 10.1371\/journal.pone.0059868","journal-title":"PLoS One"},{"key":"2885_CR8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-3083.2009.02229.x","volume":"69","author":"AF Zadura","year":"2009","unstructured":"Zadura AF, Theander E, Blom AM, Trouw LA (2009) Complement inhibitor C4b-binding protein in primary Sj\u00f6gren\u2019s syndrome and its association with other disease markers. Scand J Immunol 69:374\u2013380. doi: 10.1111\/j.1365-3083.2009.02229.x","journal-title":"Scand J Immunol"},{"key":"2885_CR9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","volume":"44","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Yag\u00fce J, Akasbi M, Bautista R, Ruano M et al (2005) Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sj\u00f6gren\u2019s syndrome. Rheumatology 44:89\u201394. doi: 10.1093\/rheumatology\/keh407","journal-title":"Rheumatology"},{"key":"2885_CR10","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","volume":"50","author":"E Theander","year":"2004","unstructured":"Theander E, Manthorpe R, Jacobsson LTH (2004) Mortality and causes of death in primary Sj\u00f6gren\u2019s syndrome: a prospective cohort study. Arthritis Rheum 50:1262\u20131269. doi: 10.1002\/art20176","journal-title":"Arthritis Rheum"},{"key":"2885_CR11","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1681\/ASN.V131242","volume":"13","author":"V Nickeleit","year":"2002","unstructured":"Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ (2002) Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 13:242\u2013251","journal-title":"J Am Soc Nephrol"},{"key":"2885_CR12","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.healun.2004.07.021","volume":"24","author":"RN Smith","year":"2005","unstructured":"Smith RN, Brousaides N, Grazette L, Saidman S, Semigran M, Disalvo T et al (2005) C4d deposition in cardiac allografts correlates with alloantibody. J Heart Lung Transplant 24:1202\u20131210","journal-title":"J Heart Lung Transplant"},{"key":"2885_CR13","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/ndt\/gfg304","volume":"18","author":"V Nickeleit","year":"2003","unstructured":"Nickeleit V, Mihatsch MJ (2003) Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol Dial Transplant 18:2232\u20132239","journal-title":"Nephrol Dial Transplant"},{"key":"2885_CR14","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1002\/art.20561","volume":"50","author":"S Manzi","year":"2004","unstructured":"Manzi S, Navratil JS, Ruffing MJ, Liu CC, Danchenko N, Nilson SE et al (2004) Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum 50:3596\u20133604","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2885_CR15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E et al (2010) EULAR Sj\u00f6gren\u2019s Task Force. EULAR Sj\u00f6gren\u2019s\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 69(6):1103\u20131109","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2885_CR16","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A et al (2011) EULAR Sj\u00f6gren\u2019s Task Force. EULAR Sj\u00f6gren\u2019s\u2019s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 70(6):968\u2013972","journal-title":"Ann Rheum Dis"},{"key":"2885_CR17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2007.05.002","volume":"7","author":"C Daridon","year":"2008","unstructured":"Daridon C, Youinou P, Pers JO (2008) BAFF, APRIL, TWE-PRIL: who\u2019s who? Autoimmun Rev 7:267\u2013271","journal-title":"Autoimmun Rev"},{"key":"2885_CR18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10875-005-4091-5","volume":"25","author":"MV Jonsson","year":"2005","unstructured":"Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K (2005) Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sj\u00f6gren\u2019s syndrome. J Clin Immunol 25:189\u2013201","journal-title":"J Clin Immunol"},{"key":"2885_CR19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4049\/jimmunol.166.1.6","volume":"166","author":"J Zhang","year":"2001","unstructured":"Zhang J, Roschke V, Baker KP, Wang Z, Alarc\u00f3n GS, Fessler BJ et al (2001) Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 166:6\u201310","journal-title":"J Immunol"},{"key":"2885_CR20","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","volume":"44","author":"GS Cheema","year":"2001","unstructured":"Cheema GS, Roschke V, Hilbert DM, Stohl W (2001) Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 44:1313\u20131319","journal-title":"Arthritis Rheum"},{"key":"2885_CR21","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1182\/blood-2009-05-217513","volume":"114","author":"XJ Zhu","year":"2009","unstructured":"Zhu XJ, Shi Y, Peng J, Guo CS, Shan NN, Qin P et al (2009) The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood 114:5362\u20135367","journal-title":"Blood"},{"key":"2885_CR22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/ar2210","volume":"9","author":"A Hansen","year":"2007","unstructured":"Hansen A, Lipsky PE, D\u00f6rner T (2007) B cells in Sj\u00f6gren\u2019s syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 9:218. doi: 10.1186\/ar2210","journal-title":"Arthritis Res Ther"},{"key":"2885_CR23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ajh.21815","volume":"85","author":"MS Davids","year":"2010","unstructured":"Davids MS, Murali MR, Kuter DJ (2010) Serum free light chain analysis. Am J Hematol 85:787\u2013790","journal-title":"Am J Hematol"},{"key":"2885_CR24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","volume":"46","author":"JP Ioannidis","year":"2002","unstructured":"Ioannidis JP, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 46:741\u2013747","journal-title":"Arthritis Rheum"},{"key":"2885_CR25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","volume":"106","author":"SV Rajkumar","year":"2005","unstructured":"Rajkumar SV, Kyle RA, Therneau TM, Melton LJ 3rd, Bradwell AR, Clark RJ et al (2005) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 106:812\u2013817","journal-title":"Blood"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2885-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-013-2885-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2885-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T19:05:37Z","timestamp":1646939137000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-013-2885-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,29]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["2885"],"URL":"https:\/\/doi.org\/10.1007\/s00296-013-2885-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,29]]}}}